These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30464609)

  • 41. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
    Chi F; Chen L; Jin X; He G; Liu Z; Han S
    Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins.
    Burgute BD; Peche VS; Steckelberg AL; Glöckner G; Gaßen B; Gehring NH; Noegel AA
    Nucleic Acids Res; 2014 Mar; 42(5):3177-93. PubMed ID: 24353314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer
    Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY
    World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
    Rabi T; Huwiler A; Zangemeister-Wittke U
    Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
    Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
    Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.
    Zhu Q; Liang X; Dai J; Guan X
    Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
    Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
    J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress.
    Zhou Y; Liang X; Chang H; Shu F; Wu Y; Zhang T; Fu Y; Zhang Q; Zhu JD; Mi M
    Cancer Sci; 2014 Oct; 105(10):1279-87. PubMed ID: 25088800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer.
    Albert JM; Kim KW; Cao C; Lu B
    Mol Cancer Ther; 2006 May; 5(5):1183-9. PubMed ID: 16731750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Overexpression of autophagy-related gene 3 promotes autophagy and inhibits salinomycin-induced apoptosis in breast cancer MCF-7 cells].
    Li F; Huang G; Peng P; Liu Y; Li S; Liu L; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):162-168. PubMed ID: 30890503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
    Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.
    Du L; Li X; Zhen L; Chen W; Mu L; Zhang Y; Song A
    Mol Med Rep; 2018 May; 17(5):7163-7169. PubMed ID: 29568883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
    Chi Y; Xu H; Wang F; Chen X; Shan Z; Sun Y; Fan Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2583-2589. PubMed ID: 30049438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway.
    Xia E; Zhou X; Bhandari A; Zhang X; Wang O
    Cancer Manag Res; 2018; 10():1575-1583. PubMed ID: 30038517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.
    Zang HY; Gong LG; Li SY; Hao JG
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):249-257. PubMed ID: 31957838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.